Statement re extension to Standstill Agreement

Consort Healthcare (Tameside) PLC
18 November 2024
 

 

CONSORT HEALTHCARE (TAMESIDE) PLC

 

The outstanding 1.9810 per cent. Index-Linked Guaranteed Secured Bonds due 2041

ISIN XS0321115130

(the "Notes")

 

RNS REGARDING CHANGE OF OWNERSHIP AND SHORT-TERM STANDSTILL

 

Consort Healthcare (Tameside) plc

 

 

London, 18 November 2024 - Consort Healthcare (Tameside) plc (the "Company"), a project company for the Private Finance Initiative (PFI) concession contract to design, construct, finance, maintain and manage the lifecycle costs of hospital facilities in Tameside for the Tameside & Glossop Integrated Care NHS Foundation Trust (the "Trust") provides an update regarding the standstill arrangements

 

The previous standstill arrangement between the Company and the Trust expired on 01 November 2024 and the parties have agreed to a short-term extension until 01 December 2024 while discussions continue as to whether a potential settlement arrangement can be reached.

 

There is no certainty as to whether such discussions will be successful. If unsuccessful, there is a high likelihood the Company will enter an insolvency process.

 

The Company will provide further updates to the market in due course.

 

This announcement is given by the Company. 

Enquiries:  consorttameside@vercitygroup.com

 

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT QUALIFIES OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU NO. 596/2014), AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings